4,0
20. Dez. 2023
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great flagship product with a big, untapped market and growing levels of evidence. You can get easily behind the mission and feel connected to the patient impact.
Kontras
The sales growth (and stock price) has been lower than target, partially due to lack of focus from the leadership.